Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer
Interventions: DRUG: Niraparib|DRUG: Dostarlimab|RADIATION: Radiation therapy
Sponsor: Massachusetts General Hospital
Collaborators: Sibley Memorial Hospital|Duke University|University of Pennsylvania